References
Janitza S, Majumder M, Mendolia F, et al. Elaborator: a novel app for insights into laboratory data of clinical trials. Ther Innov Regul Sci. 2021. https://doi.org/10.1007/s43441-021-00318-4.
Barmaz Y, Ménard T. Bayesian modeling for the detection of adverse events underreporting in clinical trials. Drug Saf. 2021. https://doi.org/10.1007/s40264-021-01094-8.
Koneswarakantha B, Barmaz Y, Ménard T, et al. Follow-up on the use of advanced analytics for clinical quality assurance: bootstrap resampling to enhance detection of adverse event under-reporting. Drug Saf. 2021;44:121–3. https://doi.org/10.1007/s40264-020-01011-5.
Openpharma Github Repository. https://github.com/openpharma. Accessed 8 Jul 2021
Ménard T, Young K, Emerson J, et al. Cross-company collaboration to leverage analytics for clinical quality and accelerate drug development: the IMPALA industry group. CPT Pharmacometrics Syst Pharmacol. 2021. https://doi.org/10.1002/psp4.12677.
Funding
No funding was provided for writing this letter.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Björn Koneswarakantha and Timothé Ménard were employed by F. Hoffmann-La Roche at the time this letter was completed.
Rights and permissions
About this article
Cite this article
Koneswarakantha, B., Ménard, T. Open Source Analytics App for Clinical Trials: Letter to the Editor—A Novel App for Insights into Laboratory Data of Clinical Trials. Ther Innov Regul Sci 55, 1107–1108 (2021). https://doi.org/10.1007/s43441-021-00331-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43441-021-00331-7